Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01096290Phase 4Terminated
Phase 4, randomised, double-blind trial in constipation comparing Lubiprostone with Placebo (2 arms). Primary endpoint: Relief of Constipation Defined by Modified ROME Criteria at 30 days. Started Apr 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01096290.